Protein kinases play an important role in the regulation of epithelial tight junctions. In the present study, we investigated the role of PKCζ (protein kinase Cζ ) in tight junction regulation in Caco-2 and MDCK (Madin-Darby canine kidney) cell monolayers. Inhibition of PKCζ by a specific PKCζ pseudosubstrate peptide results in redistribution of occludin and ZO-1 (zona occludens 1) from the intercellular junctions and disruption of barrier function without affecting cell viability. Reduced expression of PKCζ by antisense oligonucleotide or shRNA (short hairpin RNA) also results in compromised tight junction integrity. Inhibition or knockdown of PKCζ delays calcium-induced assembly of tight junctions. Tight junction disruption by PKCζ pseudosubstrate is associated with the dephosphorylation of occludin and ZO-1 on serine and threonine residues. PKCζ directly binds to the C-terminal domain of occludin and phosphorylates it on threonine residues. Thr 403 , Thr 404 , Thr 424 and Thr 438 in the occludin C-terminal domain are the predominant sites of PKCζ -dependent phosphorylation. A T424A or T438A mutation in full-length occludin delays its assembly into the tight junctions. Inhibition of PKCζ also induces redistribution of occludin and ZO-1 from the tight junctions and dissociates these proteins from the detergent-insoluble fractions in mouse ileum. The present study demonstrates that PKCζ phosphorylates occludin on specific threonine residues and promotes assembly of epithelial tight junctions.
INTRODUCTION
Tight junctions in different epithelia form a barrier to the diffusion of macromolecules across the epithelial monolayer [1] . In the gastrointestinal tract, lung and kidney, the epithelial tight junctions prevent the diffusion of allergens, toxins and pathogens from the external environment into the tissues. Disruption of tight junctions and the attenuation of epithelial barrier function are involved in the pathogenesis of gastrointestinal, pulmonary and renal diseases [2] [3] [4] . Tight junctions also play a barrier function in the epithelium to maintain the distinct molecular identities of the apical and basolateral membranes, thus determining the polarity of epithelial cells. A sustained loss of tight junction integrity leads to epithelial-mesenchymal transition.
Tight junctions are formed by the assembly of a multi-protein complex at the apical end of the cells. The transmembrane proteins of tight junctions include occludin, claudin, junctional adhesion molecule and tricellulin [1, 5, 6] . The intracellular Cterminal domains of these proteins interact with the scaffold proteins ZO (zona occludens)-1, ZO-2 and ZO-3 [7] , which in turn interact with other soluble proteins (7H6, cingulin and symplekin) [8, 9] and the actin cytoskeleton [10] . Dissociation of proteinprotein interactions or disassembly of actin cytoskeleton leads to disruption of tight junctions and an increase in paracellular permeability in different epithelia. Similarly, disruption of tight junctions by inflammatory mediators such as hydrogen peroxide [11] , acetaldehyde [12, 13] , tumour necrosis factor-α [14] [15] [16] and interferon-γ [17, 18] also results in dissociation of tight junction protein complexes.
A significant body of evidence indicates that the assembly and the maintenance of tight junctions are regulated by several components of intracellular signalling pathways [11] . Pharmacological and molecular studies have demonstrated that tight junctions are regulated by protein tyrosine kinases such as c-Src, c-Yes [19] [20] [21] [22] [23] and protein serine/threonine kinases such as PKC (protein kinase C) [13, [24] [25] [26] [27] [28] [29] , MAPK (mitogen-activated protein kinase) [30] and PKA (protein kinase A) [31, 32] . A number of these signalling proteins are localized at the tight junctions and seem to interact directly with the tight junction proteins.
Occludin spans the membrane four times to form two extracellular loops and one intracellular loop, and the Nterminal and C-terminal domains project into the intracellular compartment. At the C-terminal domain it interacts with ZO-1, and this interaction is essential for the assembly of tight junctions. Occludin is highly phosphorylated on serine/threonine residues and the phosphorylated occludin is associated with the actinrich detergent-insoluble fractions, suggesting that phosphorylated occludin is associated with the intact tight junction [33] . Disruption of tight junctions by calcium depletion [34] , phorbol ester [35] and pathogens [36] results in dephosphorylation of occludin on serine/threonine residues. Therefore dynamic phosphorylation of occludin seems to play an important role in the assembly and disassembly of tight junctions. Very little is known about the protein kinases and protein phosphatases involved in this regulation of occludin phosphorylation. Although a previous study has shown that the protein serine/threonine phosphatases PP2A and PP1 play an important role in occludin dephosphorylation and destabilization of tight junctions [34] , PKCη is involved in occludin phosphorylation and assembly of tight junctions [26] . The atypical PKCs PKCζ and PKCλ/ι are closely associated with the tight junctions and implicated in the assembly of tight junctions [37] [38] [39] . However, the precise role of these PKC isoforms in assembly or maintenance of tight junctions is unknown.
In the present study, we used Caco-2 (colon adenocarcinoma cell) and MDCK (Madin-Darby canine kidney) cell monolayers to investigate the role of PKCζ in the regulation of epithelial tight junctions. Our results show that: (i) inhibition or knockdown of PKCζ leads to disruption of tight junctions and prevents tight junction assembly in both Caco-2 and MDCK cell monolayers; (ii) PKCζ activity is involved in serine/threonine phosphorylation of occludin and ZO-1; (iii) PKCζ directly interacts with the Cterminal domain of occludin and phosphorylates it on specific threonine residues; (iv) phosphorylation of occludin on Thr 424 and Thr 438 is required for its optimal assembly into the junctions; and (v) inhibition of PKCζ also disrupts tight junctions in mouse ileum.
MATERIALS AND METHODS

Chemicals
Cell culture and transfection reagents were purchased from Gibco-BRL. FITC-inulin, GSH, leupeptin, aprotinin, bestatin, pepstatin A, PMSF, GSH-agarose, Triton X-100, vanadate and Protein ASepharose were purchased from Sigma Chemical Company. All other chemicals were of analytical grade and purchased either from Sigma Chemical Company or Fisher Scientific. The PKCζ -PS (PKCζ pseudosubstrate) peptide with the sequence Myr-SIYRRGARRWRKL and the control peptide with a scrambled sequence (Myr-SRIYRGRARWRLK) were custom-synthesized by GenScript.
Expression constructs and recombinant proteins
The pEGFP-occludin [human; where EGFP is enhanced GFP (green fluorescent protein)] construct was generated as described previously [26] . The cytoplasmic C-terminal region of human occludin encoding amino acids 378-522 (Ocl-C) was amplified from the pEGFP-occludin vector, and was cloned into the pGEX-2T vector (GE Healthcare). Point mutations of Thr 400 , Thr 403 , Thr 404 , Thr 424 and Thr 438 to alanine were introduced into wildtype GFP-occludin or the GST (glutathione transferase)-Ocl-C nucleotide sequence as described before. Recombinant Ocl-C was produced as a GST-fusion protein (GST-Ocl-C) in Escherichia coli BL21DE cells and was purified using GSH-agarose as described previously [40] . The cDNA clone for human occludin was a gift from Dr Van Italie and James M. Anderson (University of North Carolina, Chapel Hill, NC, U.S.A.).
Antibodies
Mouse monoclonal anti-PKCζ and HRP (horseradish peroxidase)-conjugated anti-GST antibodies were purchased from BD Transduction Laboratories. Mouse monoclonal anti-occludin, rabbit polyclonal anti-ZO-1, HRP-conjugated antioccludin, and rabbit polyclonal anti-p-Thr (phosphothreonine) and anti-p-Ser (phosphoserine) antibodies were purchased from Zymed Laboratories. Alexa Fluor ® 488-conjugated anti-mouse IgG and anti-rabbit IgG antibodies were obtained from Molecular Probes. Cy3 (indocarbocyanine)-conjugated anti-rabbit IgG, HRP-conjugated anti-mouse IgG, anti-β-actin, rabbit polyclonal anti-PKCζ and HRP-conjugated anti-rabbit IgG antibodies were purchased from Sigma Chemical Company.
Antisense oligonucleotides and shRNA (short hairpin RNA) for PKCζ
A vector-based shRNA method was used to silence the gene expression of human PKCζ . Two targeting sequences were chosen against the nucleotide sequence of human (Z15108.1) and canine PKCζ (XM_536716) genes using the Dharmacon website [http://www.dharmacon.com/; target: CCATGAAAGTGGTGA-AGAA (nucleotide position 818-836 in human and 693-711 in canine)]. The sequences were verified further by BLAST search on the known human genome databases, and no matches were found other than PKCζ , confirming the uniqueness of these sequences. It was a 100 % match for the human and canine PKCζ sequences, whereas it was a <50 % match with human PKCλ/ι. To construct the shRNA vectors, a pair of oligonucleotides containing the antisense sequence, a hairpin loop region (TTGATATCCG) and the sense sequence with cohesive BamHI and HindIII sites was synthesized (Sigma Genosys) as follows: top strand1, 5 -GGATCCCGCCATGAAAGTGGTG-AAGAATTGATATCCGTTCTTCACCACTTTCATGGTTTTT-TCCAAAAGCTT-3 ; and bottom strand, 5 -AAGCTTTTG-GAAAAAACCATGAAAGTGGTGAAGAACGGATATCAAT-TCTTCACCACTTTCATGGCGGGATCC-3 . The top and bottom strands were annealed and cloned into BamHI and HindIII sites of the pRNAtin-H1.2/neo vector (GenScript), which induces expression of shRNA by the H1.2 promoter and AcGFP protein by the CMV (cytomegalovirus) promoter. Successful insertion of the shRNA constructs into the vector was confirmed by releasing the oligonucleotides by digesting with BamHI and HindIII, and by nucleotide sequencing.
We designed two antisense oligonucleotides against the nucleotide sequence of human PKCζ . Target sequences were compared with nucleotide sequences of other PKC isoforms, using the CLUSTAL W program, which aligned the nucleotide sequences of PKCs to enable us to pinpoint areas in the nucleotide sequences of the enzyme which were unique and did not match the sequences in other PKC isoforms. The antisense sequences for selected sense sequences were used for synthesis of oligonucleotides as follows: AS-1, CTCTCTTTGGGG-TCCTTATT (to the PKCζ target sequence 1331-1350) and AS-2, TGCCGTAGTCTGTGAGCTTG (to the PKCζ target sequence 1641-1660). We also designed a control missense oligonucleotide with mutated sequence of AS-1 (CTCTATT-TGCGGTTCTGATT). BLAST analysis indicated that the AS-1 sequence has 94 % match and 100 % coverage with the canine PKCζ gene sequence, whereas AS-2 has only a 50 % match. This is reflected in their ability to knockdown PKCζ in MDCK cells; AS-1 is more effective than AS-2 in reducing PKCζ expression in MDCK cells.
Cell culture
Caco-2 cells (A.T.C.C.) were grown under standard cell culture conditions as described previously [13, 26] . Cells were grown on polyester membranes in Transwell inserts (6.5 mm, 12 mm or 24 mm; Costar), and experiments were conducted on days 11-13 (6.5 
Transfection of antisense oligonucleotides and shRNA
Caco-2 cells (125 000 cells/well) were incubated in 1 ml antibiotic-free DMEM (Dulbecco's modified Eagle's medium) containing 10 % FBS (fetal bovine serum), 1 μg of DNA plasmid (empty vector or shRNA) or oligonucleotides (missense, AS-1 or AS-2), 1 μl of Plus reagent, and 3 μl of Lipofectamine TM -LTX for each well. After 20 h, the cell monolayers were trypsinized and seeded on to 6.5 mm transwells. Experiments were conducted on days 3-5 after transfection. Reduction in PKCζ protein expression was verified by immunoblot analysis.
Cell viability assessment
Cell viability was assessed by measuring LDH (lactate dehydrogenase) activity in the incubation medium 3 h after incubation with or without PKCζ -PS. LDH activity was measured using a kit from Sigma Chemical Company. The metabolic activity of cells was evaluated by using WST-1 (water-soluble tetrazolium salt 1) cell proliferation assay reagent from Clontech, according to the manufacturer's instructions.
Measurement of TER
TER was measured as described previously [13, 26] using a Millicell-ERS Electrical Resistance System (Millipore). TER was calculated as ·cm 2 by multiplying it with the surface area of the monolayer. The resistance of the polyester membrane in Transwells (approximately 30 ·cm 2 ) was subtracted from all readings.
Unidirectional flux of inulin
Transwells with the cell monolayers were incubated under different experimental conditions in the presence of FITC-inulin (0.5 mg/ml) in the basal well. At various times during the experiment, 50 μl of apical and basal media were withdrawn, and the fluorescence was measured using a fluorescence plate reader (BioTEK Instruments). The flux into the apical well was calculated as the percentage of total fluorescence administered into the basal well/h per cm 2 surface area.
Immunofluorescence microscopy
Cell monolayers were washed with PBS and fixed in acetone/methanol (1:1) at 0 • C for 5 min. Fixed cell monolayers were blocked in 3 % (w/v) non-fat dried skimmed milk powder in TBST (Tris-buffered saline plus Tween 20: 20 mM Tris/HCl, pH 8.0, 150 mM NaCl and 0.5 % Tween 20) and incubated for 1 h with primary antibodies (rabbit polyclonal anti-ZO-1 and mouse monoclonal anti-occludin antibodies), followed by incubation for 1 h with secondary antibodies (goat Alexa Fluor ® 488-conjugated anti-mouse IgG and Cy3-conjugated antirabbit IgG antibodies). The fluorescence was visualized using a Zeiss LSM 5 Laser Scanning Confocal Microscope, and images from Z-series sections (1 μm) were collected by using Zeiss LSM 5 Pascal, the confocal microscopy software (Release 3.2). Images were stacked using ImageJ software (NIH), and processed by Adobe Photoshop (Adobe Systems).
Preparation of detergent-insoluble fractions
Triton-insoluble fractions were prepared as described previously [33] . Ileal mucosa was incubated for 5 min with lysis buffer-CS (50 mM Tris/HCl, pH 7.4, 1.0 % Triton X-100, 5 mM EGTA, 10 mM sodium fluoride, 2 μg/ml leupeptin, 10 μg/ml aprotinin, 10 μg/ml bestatin, 10 μg/ml pepstatin A, 1 mM vanadate and 1 mM PMSF). Cell lysates were centrifuged at 15 600 g for 4 min at 4
• C to sediment the high-density actin-rich fraction. The pellet was suspended in 200 μl of lysis buffer D (0.3 % SDS in 20 mM Tris/HCl buffer, pH 7.4, containing 1 mM sodium orthovanadate, 10 mM sodium fluoride, 1 mM PMSF and 10 μg/ml protease inhibitor cocktail). Protein concentrations in different fractions were measured using the BCA (bichinchonic acid) method (Pierce Biotechnology). Triton-insoluble and -soluble fractions were mixed with an equal volume of Laemmli sample buffer (2× concentrated) and heated at 100
• C for 10 min.
Immunoprecipitation
Caco-2 cell monolayers (24 mm Transwells) were washed with ice-cold PBS and proteins extracted in immunoprecipitation buffer (50 mM Tris/HCl, pH 7.4, 1 % Nonidet P40, 2 mM EDTA, 2 mM EGTA, 10 mM sodium fluoride, 1 mM vanadate and protease inhibitor cocktail as described above). Protein extracts (1.0 mg of protein/ml) were incubated with 2 μg of anti-occludin antibodies at 4
• C for 16 h. Immune complexes were isolated by precipitation using Protein A-Sepharose (for 1 h at 4
• C). For immunoprecipitation of p-Thr (phosphothreonine) and pSer (phosphoserine), proteins were extracted in lysis buffer D and heated for 10 min at 100
• C, followed by centrifugation at 10 000 g for 10 min at 4
• C. The clear supernatant was used for immunoprecipitation.
Immunoblot analysis
Proteins were separated by SDS/PAGE (7 % gels) and transferred on to PVDF membranes. Membranes were blotted for different proteins by using specific antibodies in combination with HRP-conjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG antibodies. HRP-conjugated anti-GST antibody was used for immunoblot analysis of GST or GST-Ocl-C. The blot was developed using ECL (enhanced chemiluminescence) (GE Healthcare).
Pairwise binding assay
To determine the direct interaction between occludin and PKCζ , GST-Ocl-C (10 μg) was prepared as described previously [40] and incubated with recombinant His-tagged PKCζ (30-500 ng) in PBS containing 0.2 % Triton X-100, 1 mM vanadate and 10 mM sodium fluoride for 16 h at 4
• C on an inverter. GST-Ocl-C was pulled down by binding to 20 μl of 50% GSH-agarose slurry at 4
• C for 1 h. The amounts of PKCζ bound to the GSHagarose pull-down were determined by immunoblot analysis. Non-specific binding was determined by carrying out the binding with GST, instead of GST-Ocl-C.
Occludin phosphorylation in vitro
GST-Ocl-C (10 μg) was incubated with 500 ng of active PKCζ (in 20 mM Mops pH 7.2, containing 25 mM 2-glycerophosphate, 2.25 mM MgCl 2 , 0.2 mM ATP and 1 mM dithiothreitol) or with 500 ng of PKCη as described in [26] . Following a 3 h incubation at 30
• C, the reaction mixture was immunoblotted for p-Thr.
Ileal assay
Using the IACUC (Institutional Animal Care and Use Committee)-approved protocol, adult male mice (C57Bl/6) were anaesthetized with isoflurane. The small intestine was removed, and the distal one-third was separated as ileum and placed in KRB (Krebs-Ringer-bicarbonate) buffer aerated with 100 % oxygen in an ice bath. Animals were killed immediately after removing the intestine by cervical dislocation under isoflurane anaesthesia.
Ileum was cut open longitudinally and segments (∼0.5 cm) were incubated in DMEM with or without various concentrations of PKCζ -PS in an incubator at 37
• C. After 1 h, tissues were either cryofixed in OCT TM or mucosal-scraped to prepare Tritoninsoluble fractions. Cryosections were stained for occludin and ZO-1 or E-cadherin and β-catenin by immunofluorescence. Triton-insoluble and -soluble fractions were immunoblotted for occludin and ZO-1. The incubation medium was assayed for LDH activity.
Statistics
Comparison between two groups was made by Student's t tests for grouped data. Significance in all tests was set at 95 % or greater confidence level.
RESULTS
PKCζ -PS disrupts tight junctions in Caco-2 cell monolayers
To determine the role of PKCζ activity in the maintenance of tight junction integrity, we evaluated the effect of PKCζ -PS on tight junction integrity in Caco-2 cell monolayers. Administration of PKCζ -PS decreased TER ( Figure 1A ) and increased inulin permeability ( Figure 1B ) in a time- (Figures 1A and 1B ) and dose-( Figures 1C and 1D ) dependent manner. Control peptide up to 50 μM did not cause significant change in TER or inulin permeability; however, at 100 μM concentration, the control peptide slightly, but significantly, increased inulin permeability and reduced TER. PKCζ -PS did not increase LDH activity in the incubation medium ( Figure 1E ) or reduce the mitochondrial activity ( Figure 1F ). Confocal microscopy showed that occludin and ZO-1 are co-localized at the intercellular junctions in control cell monolayers ( Figure 1G ). PKCζ -PS induced the redistribution of occludin and ZO-1 from the intercellular junctions into the intracellular compartment.
PKCζ -PS delays calcium-induced tight junction assembly in Caco-2 cell monolayers
To determine the requirement of PKCζ activity for the assembly of tight junctions, we evaluated the effect of PKCζ -PS on the development of barrier function during calcium-induced tight junction reassembly. Treatment of cell monolayers with EGTA rapidly reduced TER (Figure 2A ) and increased inulin permeability ( Figure 2B ). Replacement of calcium gradually increased TER and reduced inulin permeability. The calciuminduced increase in TER and decrease in inulin permeability were significantly attenuated by the presence of PKCζ -PS. EGTA treatment induced the redistribution of occludin and ZO-1 from the intercellular junctions into the intracellular compartments ( Figure 2C ), which were reassembled back at the intercellular junctions during calcium replacement. The presence of PKCζ -PS prevented calcium-induced reassembly of occludin and ZO-1 into intercellular junctions ( Figure 2C ). 
PKCζ -PS disrupts tight junctions and delays tight junction assembly in MDCK cells
The results described above indicate that PKCζ activity plays a critical role in the assembly and maintenance of tight junctions in Caco-2 cell monolayers (an intestinal epithelium). To investigate whether a similar mechanism exists in another epithelium, we evaluated the effect of PKCζ -PS on the maintenance of tight junction integrity and the de novo assembly of tight junctions in MDCK cell monolayers (renal tubular epithelium). PKCζ -PS increased inulin permeability in a time-( Figure 3A ) and dose-( Figure 3B ) dependent manner without inducing LDH release ( Figure 3C ) or loss of cell viability ( Figure 3D ). PKCζ -PSmediated disruption of the barrier to inulin permeability was associated with a redistribution of occludin and ZO-1 from the intercellular junctions ( Figure 3E ). The presence of PKCζ -PS also delayed the calcium-induced reassembly of tight junctions in MDCK cells ( Figure 3F ).
Figure 4 Inhibition of PKCζ activity disrupts adherens junctions in Caco-2 cell monolayers
Caco-2 cell monolayers were incubated with or without PKCζ -PS (50 μM) for 2 h. Cell monolayers were fixed and stained for E-cadherin and β-catenin using immunofluorescence. Images were observed by confocal microscopy.
PKCζ -PS disrupts adherens junctions in Caco-2 cell monolayers
To determine the role of PKCζ in the maintenance of adherens junctions, we analysed the effect of PKCζ -PS on distribution of E-cadherin and β-catenin. E-cadherin and β-catenin were colocalized at the intercellular junctions in control cell monolayers (Figure 4 ). PKCζ -PS administration induced a redistribution of E-cadherin and β-catenin from the intercellular junctions into the intracellular compartment in a dose-dependent manner.
Knockdown of PKCζ attenuates tight junction integrity in Caco-2 cell monolayers
PKCζ -PS is also likely to inhibit PKCλ [41] , and therefore we designed antisense oligonucleotides specific to the nucleotide sequence of human PKCζ (AS-1 and AS-2). Caco-2 cells were transfected with AS-1, AS-2 or missense oligonucleotides. Transfection with AS-1 and AS-2 reduced the levels of PKCζ in Caco-2 cells without affecting the levels of PKCλ (Figures 5A and 5B). Tight junction integrity was evaluated 3 days after transfection. Both AS-1 and AS-2 significantly reduced TER ( Figure 5C ) and enhanced inulin permeability ( Figure 5D ). Knockdown of PKCζ by AS-2 caused redistribution of occludin and ZO-1 from intercellular junctions into the intracellular compartments ( Figure 5E ), indicating a delayed assembly of tight junctions in the absence of optimal levels of PKCζ .
Transfection with AS-1 significantly reduced the level of PKCζ in MDCK cells ( Figure 6A ). AS-1 reduced TER ( Figure 6B ) and increased inulin permeability ( Figure 6C ). Knockdown of PKCζ by AS-1 also resulted in redistribution of occludin and ZO-1 from the intercellular junctions into the intracellular compartments ( Figure 6D ), indicating a delayed assembly of tight junctions.
We also designed a shRNA specific for the nucleotide sequence of the canine PKCζ gene (which also showed a 100 % match with the human PKCζ gene sequence) and inserted it into pRNAtinH1.2/neo vector that also contained a gene for AcGFP, so that transfected cells could be distinguished from nontransfected cells in the same cell monolayer. Transfection of shRNA into MDCK cells resulted in significant reduction in the level of PKCζ ( Figure 6E ). Cell monolayers transfected with shRNA exhibited significantly lower TER ( Figure 6F ) and higher inulin permeability ( Figure 6G ) compared with those in vectortransfected cell monolayers, indicating that reduced expression of PKCζ leads to delayed development of barrier function. Immunofluorescence microscopy showed the presence of GFP in approximately 35 % of cells in both vector-and shRNAtransfected cells ( Figure 6H ). Co-immunostaining for GFP and ZO-1 showed that ZO-1 was localized at the intercellular junctions in vector-transfected cells, in both GFP-positive and GFP-negative cells. On the other hand, in shRNA-transfected cells, GFP-positive cells showed an intracellular distribution of ZO-1 ( Figure 6H ), whereas in GFP-negative cells, ZO-1 was localized predominantly at the intercellular junctions. Calcium-induced development of barrier function was significantly delayed in shRNA-transfected cells compared with that in vector-transfected cells ( Figure 6I ).
PKCζ activity is involved in serine/threonine phosphorylation of occludin and ZO-1
To determine the effect of PKCζ activity on serine and threonine residue phosphorylation of occludin, we immunoprecipitated pSer and p-Thr from denatured protein extracts from control and PKCζ -PS-treated Caco-2 cell monolayers and immunoblotted them for occludin and claudin-1. The threonine and serine residue phosphorylation of occludin remained unaffected during the incubation time in the absence of PKCζ -PS (results not shown). The presence of PKCζ -PS caused a rapid reduction in the levels of serine/threonine-phosphorylated occludin and ZO-1 ( Figure 7A ). Results also showed that claudin-1 is phosphorylated on both serine and threonine residues. However, claudin-1 phosphorylation was unaffected by PKCζ -PS ( Figure 7A ). We have shown previously that anti-p-Thr and anti-p-Ser antibodies, under our experimental conditions, are quite specific in detecting p-Thr and p-Ser [34] . We performed an additional experiment to rule out the non-specific pull-down of occludin and claudin-1 during immunoprecipitation. Immunoprecipitation of threoninephosphorylated occludin and claudin-1 using the anti-p-Thr antibody was prevented by the inclusion of excessive amounts (25 μM) of p-Thr-peptide, but not by p-Ser-peptide, indicating a specific pull-down of threonine-phosphorylated occludin and claudin-1 ( Figure 7B ). Similarly, immunoprecipitation of serinephosphorylated claudin-1 was prevented by p-Ser-peptide, but not by p-Thr-peptide. Immunoprecipitation of occludin using the antip-Ser antibody, however, was reduced by both p-Thr-peptide and p-Ser-peptide. This indicates that anti-p-Ser antibodies may be specific only for certain proteins. Therefore results obtained from experiments using anti-p-Ser antibodies should be viewed with caution. On the other hand, the anti-p-Thr antibody was much more specific for threonine-phosphorylated proteins.
PKCζ directly interacts with the C-terminal domain of occludin
A previous study showed that PKCζ is localized at the vicinity of tight junctions in MDCK cell monolayers [25] . However, the direct interaction of PKCζ with tight junction proteins and its involvement in the phosphorylation of tight junction proteins is unknown. To determine the direct interaction of PKCζ with occludin, we prepared the recombinant C-terminal domain of human occludin (C-terminal 150 amino acids) as a GSTfusion protein (GST-Ocl-C). GST-Ocl-C was then incubated with various concentrations of recombinant PKCζ and the direct binding was evaluated using a GST pull-down assay. Results show that PKCζ bound to GST-Ocl-C in a dose-dependent manner ( Figures 7C and 7D ). Densitometric analysis indicated that only trace amounts of PKCζ bound to GST ( Figure 7D ).
PKCζ phosphorylates the C-terminal tail of occludin on specific threonine residues
To determine the direct role of PKCζ activity in the phosphorylation of occludin, we incubated GST-Ocl-C with recombinant PKCζ in the presence of ATP. PKCζ induced phosphorylation of GST-Ocl-C on serine and threonine residues ( Figure 7E ). The presence of PKCζ -PS in the assay mixture reduced PKCζ -mediated phosphorylation of GST-Ocl-C in a dose-dependent manner. A previous study indicated that PKCη also phosphorylates occludin on threonine residues [16] . The present study shows that PKCη-mediated occludin phosphorylation was unaffected by PKCζ -PS ( Figure 7E ), indicating the specificity of PKCζ -PS. We focused our further studies on threonine phosphorylation of occludin.
To determine the site of phosphorylation, we mutated threonine residues (selected on the basis of evolutionary conservation) in GST-Ocl-C and tested for in vitro phosphorylation by PKCζ . Mutation of Thr 400 did not influence PKCζ -mediated threonine phosphorylation, whereas T403A, T404A, T424A or T438A mutations resulted in a partial reduction in threonine phosphorylation ( Figure 7F) ; mutation of Thr 438 almost completely attenuated threonine phosphorylation of GST-Ocl-C. Images were observed using a confocal microscope.
Phosphorylation of Thr 424 and Thr 438 is required for the assembly of occludin into tight junctions
Our previous study has shown that mutation of Thr 403 and Thr 404 results in delayed assembly of occludin into tight junctions [26] .
To determine the role of occludin phosphorylation on Thr 424 and Thr 438 , we mutated these residues in full-length occludin and expressed them as GFP-fusion proteins in MDCK epithelial cells and Rat-1 fibroblasts. Cell monolayers were fixed during Ca 2 + -induced tight junction assembly and were stained for GFP and ZO-1. Figure 8(A) shows that wild-type GFP-occludin was recruited to the intercellular junctions during calcium-induced tight junction assembly in MDCK cells. However, the T424A and T438 mutants of GFP-occludin were localized predominantly in the intracellular compartments. In Rat-1 fibroblasts, wildtype GFP-occludin was located in the plasma membranes and at the intercellular junctions and co-localized with ZO-1 ( Figure 8B ). The T424A and T438 mutants of GFP-occludin, on the other hand, were predominantly localized in the intracellular compartment.
PKCζ -PS disrupts tight junctions in mouse ileum
To confirm the physiological relevance of the observations made in cultured cell monolayers, we examined the effect of PKCζ -PS on tight junction integrity in mouse ileum. Mouse ileal strips were incubated with various concentrations of PKCζ -PS for 1 h. Confocal microscopy showed that occludin and ZO-1 were co-localized at the intercellular junctions of epithelium in the untreated ileum ( Figure 9A ). Treatment with PKCζ -PS disrupted the junctional organization of occludin and ZO-1 in a dose-dependent manner ( Figure 9A ). PKCζ -PS also induced redistribution of E-cadherin and β-catenin in a dose-dependent manner ( Figure 9B ). The PKCζ -PS-mediated disruption of tight junctions was associated with a decrease in the level of Triton X-100-insoluble fractions of occludin and ZO-1 ( Figure 9C) , with a corresponding increase in the levels of Triton X-100-soluble fractions ( Figure 9D ). To evaluate the viability of mouse intestinal tissues during incubation with PKCζ -PS, we analysed the incubation for released LDH activity. Incubation with PKCζ -PS for 2 h did not increase LDH activity in the medium ( Figure 9E ), whereas tissue damage induced by detergent dramatically increased LDH activity in the incubation medium, indicating that PKCζ -PS did not cause loss of tissue viability.
DISCUSSION
A significant body of evidence indicates that epithelial tight junctions are regulated by intracellular signalling elements including protein kinases. Evidence suggests that atypical PKCs are involved in stabilization of epithelial polarity in embryonic tissue [37, 39] and in epidermal barrier regulation [38] .
The present study provides evidence of the role of PKCζ in the assembly and maintenance of tight junctions in Caco-2 and MDCK cell monolayers. The present study also indicates that PKCζ directly interacts with occludin and induces phosphorylation of occludin on specific threonine residues. PKCζ -PS (a cell-permeant peptide) has been shown previously to inhibit PKCζ activity in various types of cells [42] . The present study shows that administration of PKCζ -PS to Caco-2 and MDCK cell monolayers result in rapid disruption of barrier function as shown by the decrease in TER and increase in inulin permeability. This barrier disruption was not associated with any loss of cell viability as shown by no change in LDH release or mitochondrial activity in the cell after 3 h of incubation with PKCζ -PS. On the other hand, barrier dysfunction induced by inhibition of PKCζ was associated with a redistribution of occludin and ZO-1 from the intercellular junctions into the intracellular compartments, indicating that PKCζ -PS caused disruption of tight junctions. In both Caco-2 and MDCK cell monolayers, calcium-induced reassembly of tight junctions was prevented by the presence of PKCζ -PS. Therefore these results indicate that PKCζ activity is required for the maintenance of tight junction integrity in both Caco-2 and MDCK epithelial cell monolayers. However, PKCζ -PS is also likely to inhibit the activity of PKCλ [41] . Therefore the possibility exists that both atypical PKCs are involved in tight junction regulation.
PKCζ -PS also caused redistribution of E-cadherin and β-catenin from the intercellular junctions into the intracellular compartments, indicating that the adherens junctions are disrupted by the inhibition of atypical PKCs. Although adherens junctions do not form a physical barrier to the diffusion of macromolecules across the epithelium, it indirectly regulates the integrity of tight junctions. Disruption of adherens junctions by calcium depletion is well known to disrupt tight junctions [43] . A recent study demonstrated that inhibition of PKCη by a specific pseudosubstrate inhibitor disrupts tight junctions without affecting the adherens junctions [26] . Therefore PKCζ may regulate the integrity of both tight junctions and adherens junctions, whereas PKCη influences only tight junctions. It is, however, not clear whether both junctions are disrupted simultaneously or one is affected prior to the other.
To distinguish the role of PKCζ from PKCλ in tight junction regulation we designed antisense oligonucleotides and shRNA to selectively knockdown PKCζ . The sequence of both antisense oligonucleotides and shRNA showed less than 40 % match with the nucleotide sequence of PKCλ. Accordingly, antisense oligonucleotides knocked down PKCζ without altering PKCλ levels. Knockdown of PKCζ disrupted barrier function, which was associated with a redistribution of tight junction proteins from the intercellular junctions into intracellular compartments. PKCζ -specific shRNA was transfected in pRNAtinH1.2/neo vector, which also contained the AcGFP gene. Similar to antisense oligonuleotides, shRNA attenuated the barrier function of MDCK cell monolayers. The expression of AcGFP in these cells allowed us to compare the GFP-positive transfected cells with the GFP-negative non-transfected cells in the same monolayer. The results confirmed that junctional distribution of ZO-1 is disrupted in GFP-positive cells, whereas ZO-1 distribution was intact at the intercellular junctions in GFP-negative cells. Antisense oligonuleotide sequences were designed against nucleotide sequence of human PKCζ , whereas shRNA was designed against canine PKCζ . The AS-1 sequence is a 94% match with the canine PKCζ sequence and, accordingly, AS-1 significantly reduced the level of PKCζ in MDCK cells, whereas AS-2 was ineffective in these cells. The shRNA sequence is 100 % match for both human and canine PKCζ gene sequences.
Loss of tight junction integrity in epithelial monolayers by calcium depletion [34] , oxidative stress [44] , acetaldehyde [13] , phorbol esters [35] and pathogens [36] is known to be associated with dephosphorylation of occludin on serine and/or threonine residues. The precise mechanism involved in this process is unclear. The present study shows that disruption of tight junctions by the inhibition of PKCζ is associated with a rapid dephosphorylation of occludin on serine and threonine residues. PKCζ may maintain the tight junction integrity by preserving the phosphorylation state of occludin. It is likely that serine/threonine phosphorylation of other tight junction proteins may also be involved. Therefore multiple mechanisms may be associated with tight junction regulation. In the present study, we focused our attention to threonine phosphorylation of occludin. The results show that PKCζ directly interacts with the C-terminal domain of occludin and phosphorylates it on threonine residues.
Our previous study showed that PKCη phosphorylates occludin on specific threonine residues [26] . In the present study, we have shown that PKCζ predominantly phosphorylates the occludin C-terminal domain on Thr 438 403 and Thr 404 is required for optimal assembly of occludin into the tight junctions [26] . To determine the role of Thr 424 and Thr 438 phosphorylation in occludin assembly into the tight junctions, we produced T424A and T438A mutations in GFP-tagged full-length occludin and expressed them in MDCK and Rat-1 fibroblasts. Wild-type occludin was localized at the intercellular junctions of MDCK cell monolayers, which co-localized with ZO-1. On the other hand, T424A and T438A mutants were localized predominantly in the intracellular compartments. In Rat-1 cells, that do not express occludin, GFP-occludin was incorporated into the plasma membrane and newly formed intercellular junctions, whereas T424A and T438A mutants were distributed in the intracellular compartments. These results indicate that phosphorylation of Thr 424 and Thr 438 is also required for the normal assembly of occludin into the tight junctions. There was a difference in the intracellular distribution of T438A mutant in MDCK cells and Rat-1 fibroblasts, the explanation for which is unclear at this time. However, it should be noted that MDCK cells express occludin, whereas Rat-1 cells do not. In MDCK cells, the T438A mutant may form dimers with the endogenous occludin and contribute to a difference in the distribution.
Caco-2 and MDCK cell monolayers have been extensively used in studies toward understanding the structure and regulation of epithelial tight junctions, and the information derived from such studies has been extended to animal tissues. The present study shows that incubation of mouse ileum with PKCζ -PS results in disruption of tight junctions. PKCζ -PS induces redistribution of occludin and ZO-1 from the intercellular junctions and reduces the levels of detergent-insoluble fractions of occludin and ZO-1. These results demonstrate that PKCζ activity is required for the maintenance of tight junction integrity in mouse ileum and confirm the physiological relevance of the observation made in Caco-2 and MDCK cell monolayers.
The present study therefore demonstrates that PKCζ activity is required for the maintenance of epithelial tight junction integrity. The mechanism of this tight junction regulation may involve PKCζ -mediated phosphorylation of occludin on specific threonine residues.
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